Pfizer Global Medical Grant – Advances in Migraine Treatment
Academic Unit: Inquire with Unit
Memorial Deadline: Wednesday 5th, October 2022
External Deadline: Tuesday 11th, October 2022
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.
Date RFP Issued: August 11, 2022
Geographic Scope: Global excluding the United States
Clinical Area: Migraine
Link to full RFP: Advances in Migraine Treatment
Application Due Date: October 11, 2022